- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04536571
Vision Stability and Preference for Soft Toric vs. Soft Spherical Contact Lenses
November 19, 2021 updated by: Coopervision, Inc.
The principal hypothesis is to be tested in this work is that vision stability (the primary outcome measure) with a spherical contact lens correction vs. a toric contact lens correction will be the same.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Detailed Description
This will be a randomised, subject-masked, crossover, bilateral non-dispensing study, controlled by cross-comparison.
Thirty subjects will use each lens type at a single visit in random sequence.
Study Type
Interventional
Enrollment (Actual)
27
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Manchester, United Kingdom, M13 9PL
- Eurolens Research
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 35 years (Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- They are aged 18-35 years and have capacity to volunteer.
- They understand their rights as a research subject and are willing and able to sign a Statement of Informed Consent.
- They are willing and able to follow the protocol.
- They are an existing wearer of soft spherical contact lenses in both eyes.
They have a spherical component of their spectacle refractive error between
-0.50DS and -6.50DS in both eyes.
They have a cylindrical component of their spectacle refractive error between
-0.75DC and -1.25DC in both eyes.
- They can be fitted satisfactorily with both lens types.
- They own an acceptable pair of spectacles.
- They agree not to participate in other clinical research for the duration of the study.
Exclusion Criteria:
- They have an ocular disorder which would normally contra-indicate contact lens wear.
- They have a systemic disorder which would normally contra-indicate contact lens wear.
- They are using any topical medication such as eye drops (including comfort drops) or ointment on a regular basis.
- They are aphakic.
- They have had corneal refractive surgery.
- They have any corneal distortion resulting from previous hard or rigid lens wear or have keratoconus.
- They are pregnant or breastfeeding.
- They have any ocular abnormality which would, in the opinion of the investigator, normally contraindicate contact lens wear.
- They have any infectious disease which would, in the opinion of the investigator, contraindicate contact lens wear or pose a risk to study personnel; or they have any immunosuppressive disease (e.g. HIV), or a history of anaphylaxis or severe allergic reaction.
- They have taken part in any other contact lens or care solution clinical trial or research, within two weeks prior to starting this study.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Crossover Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Test Contact lens
Subjects will be randomized to wear test lenses for 30 minutes, and then cross-over to control lenses.
|
Subjects will be randomized to wear test lenses for 30 minutes, and then cross-over to control lenses.
Other Names:
Subjects will be randomized to wear control lenses for 30 minutes, and then cross-over to test lenses.
Other Names:
|
Active Comparator: Control Contact lens
Subjects will be randomized to wear control lenses for 30 minutes, and then cross-over to test lenses.
|
Subjects will be randomized to wear test lenses for 30 minutes, and then cross-over to control lenses.
Other Names:
Subjects will be randomized to wear control lenses for 30 minutes, and then cross-over to test lenses.
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Vision Stability While Doing Tasks on Mobile Phone
Time Frame: 30 minutes
|
Vision stability was assessed by study subjects while doing tasks on mobile phone using a 0-100 visual analogue scales (0 - Unacceptable.
Lens cannot be worn, 100 - Excellent.
Unaware of any visual loss)
|
30 minutes
|
Vision Stability While Doing Tasks on Desktop
Time Frame: 30 minutes
|
Vision stability was assessed by study subjects while doing tasks on desktop using a 0-100 visual analogue scales (0 - Unacceptable.
Lens cannot be worn, 100 - Excellent.
Unaware of any visual loss)
|
30 minutes
|
Vision Stability While Walking
Time Frame: 30 minutes
|
Vision stability was assessed by study subjects while walking using a 0-100 visual analogue scales (0 - Unacceptable.
Lens cannot be worn, 100 - Excellent.
Unaware of any visual loss)
|
30 minutes
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Lens Fit for Test Contact Lens
Time Frame: 10 minutes
|
Lens fit was assessed for lens rotation after 10 minutes for toric fit.
Lens mislocation from optimal position was measured in 0°, 1-5°, 6-10°, 11-15°, 16-20°, More than 20°.
|
10 minutes
|
Lens Fit
Time Frame: 30 minutes
|
Lens fit was assessed as either 'acceptable' or 'not acceptable' for standard fit by study investigator.
|
30 minutes
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Philip Morgan, PhD., University of Manchester
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
September 3, 2020
Primary Completion (Actual)
June 7, 2021
Study Completion (Actual)
June 7, 2021
Study Registration Dates
First Submitted
August 14, 2020
First Submitted That Met QC Criteria
August 28, 2020
First Posted (Actual)
September 2, 2020
Study Record Updates
Last Update Posted (Actual)
November 22, 2021
Last Update Submitted That Met QC Criteria
November 19, 2021
Last Verified
November 1, 2021
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- C19-679 (EX-MKTG-115)
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
No
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
Yes
product manufactured in and exported from the U.S.
Yes
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Astigmatism
-
Ohio State UniversityActive, not recruitingAstigmatism BilateralUnited States
-
Coopervision, Inc.Completed
-
Cairo UniversityUnknown
-
Assiut UniversityCompleted
-
Ashford and St. Peter's Hospitals NHS TrustBausch & Lomb IncorporatedUnknown
-
Carl Zeiss Meditec, Inc.CompletedMixed AstigmatismUnited States
-
Johnson & Johnson Vision Care, Inc.Completed
-
Ziemer Ophthalmic Systems AGTigermed Consulting Co., LtdRecruitingMyopic AstigmatismChina
-
Bausch & Lomb IncorporatedCompleted
-
Staar Surgical CompanyActive, not recruiting
Clinical Trials on Test Contact lens
-
Johnson & Johnson Vision Care, Inc.Completed
-
Coopervision, Inc.CORECompleted
-
Coopervision, Inc.Completed
-
Johnson & Johnson Vision Care, Inc.Completed
-
Coopervision, Inc.Completed
-
Johnson & Johnson Vision Care, Inc.Completed
-
Coopervision, Inc.CORERecruiting
-
Coopervision, Inc.CORECompletedMyopiaUnited States, Canada
-
Coopervision, Inc.Completed